-

Meredith Ryan-Reid Named CEO of Versant Health, a MetLife Company

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET), announced today that Meredith Ryan-Reid has been named CEO of Versant Health, a managed vision care company and wholly-owned subsidiary of MetLife. The appointment is effective September 1.

“Meredith’s experience in multiple facets of the insurance industry, commitment to talent development, and customer-centric approach position her as the ideal leader for the Versant Health team at this stage of the company’s evolution,” said Ramy Tadros, co-chairman of the Versant Health Board of Directors and regional president, U.S. Business at MetLife. “Versant Health’s customers, members, and vision care providers will benefit from her focus on delivering innovative customer-focused solutions.”

Ryan-Reid brings almost 25 years of experience in the insurance industry to the role. Since 2013, she has held a succession of senior roles at MetLife focused on Group Benefits product development, innovation, and distribution. During her tenure she developed and launched the financial wellness app Upwise, established the company’s Financial Wellness & Engagement organization, expanded voluntary benefits distribution, and built the Accident & Health portfolio. Earlier in her career she worked on both the brokerage and carrier sides of the business.

"The breadth of Versant Health's expertise, network, and solutions is creating tremendous value across the vision care space," said Ryan-Reid. "I'm looking forward to working with the talented Versant Health team to further accelerate business growth, drive stakeholder satisfaction, and advance the company's mission."

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

About Versant Health

Versant Health, Inc., a wholly-owned subsidiary of MetLife, Inc., is one of the nation’s leading administrators of managed vision care, serving more than 38.5 million of our clients’ members nationwide. Through our Davis Vision and Superior Vision independent provider networks, we help members access the wonders of sight through healthy eyes and vision. Administering vision and eye health solutions that range from access to routine vision benefits to medical management, Versant Health has unique visibility and scale across the total eye health spectrum. As a result, our clients’ members enjoy a seamless experience with access to one of the broadest provider networks in the industry and an exclusive frame collection. Commercial groups, employer plans, and health plans that serve government-sponsored programs such as Medicaid and Medicare are among our valued customers.

Contacts

Media:

MetLife
Kim Friedman
kfriedman@metlife.com
212-578-5428

Versant Health
Rachel Pokay
rachel.pokay@versanthealth.com
210-202-8498

MetLife, Inc.

NYSE:MET

Release Summary
MetLife announced that Meredith Ryan-Reid has been named CEO of Versant Health, a managed vision care company and wholly-owned subsidiary of MetLife.
Release Versions

Contacts

Media:

MetLife
Kim Friedman
kfriedman@metlife.com
212-578-5428

Versant Health
Rachel Pokay
rachel.pokay@versanthealth.com
210-202-8498

More News From MetLife, Inc.

MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that Ramy Tadros, regional president of MetLife’s U.S. Business and head of MetLife Holdings, will participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on Wednesday, March 4, 2026, beginning at 10:25 a.m. (ET). A live webcast of the presentation will be available over the internet at https://event.summitcast.com/view/VSr8zRPFYu9jT7Rm69ptdC/fnXahDQq5cAwNB3QpWHPxq. Those who want to...

"Job Hugging" Is Undermining Workplace Outcomes: New MetLife Study

NEW YORK--(BUSINESS WIRE)--Amid persistent job market volatility and financial pressures, new MetLife data shows that while employee loyalty is rising, it may be for the wrong reasons. The latest findings from MetLife’s 2026 Employee Benefit Trends Study reveal that while 77% of employees intend to stay1 with their current employer, 56% are staying out of necessity rather than genuine commitment. This comes as financial confidence among employees has fallen to its lowest level since 2012 and 31...

MetLife Announces First Quarter 2026 Preferred Stock Dividend Actions

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary...
Back to Newsroom